Terms: = Breast cancer AND TRA AND Treatment
53 results:
1. Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor models.
Teranaka R; Fujimoto H; Masuda T; Kuroda M; Aoyagi Y; Nagashima T; Takada M; Sakakibara J; Yamada H; Yamamoto H; Kubota Y; Ohtsuka M
Breast Cancer; 2023 Nov; 30(6):1018-1027. PubMed ID: 37612442
[TBL] [Abstract] [Full Text] [Related]
2. The deformation of cancer cells through narrow micropores holds the potential to regulate genes that impact cancer malignancy.
Choi JS; Lee SH; Park HB; Chun C; Kim Y; Kim KH; Weon BM; Kim DH; Kim HJ; Lee JH
Lab Chip; 2023 Aug; 23(16):3628-3638. PubMed ID: 37448298
[TBL] [Abstract] [Full Text] [Related]
3. Simultaneous Detection of Multiple Tumor-targeted Gold Nanoparticles in HER2-Positive breast Tumors Using Optoacoustic Imaging.
Samykutty A; Thomas KN; McNally M; Hagood J; Chiba A; Thomas A; McWilliams L; Behkam B; Zhan Y; Council-Troche M; Claros-Sorto JC; Henson C; Garwe T; Sarwar Z; Grizzle WE; McNally LR
Radiol Imaging Cancer; 2023 May; 5(3):e220180. PubMed ID: 37233208
[TBL] [Abstract] [Full Text] [Related]
4. Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal cancer.
Xu M; Tsunedomi R; Kiyotani K; Tomochika S; Furuya K; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Anticancer Res; 2023 Feb; 43(2):613-620. PubMed ID: 36697107
[TBL] [Abstract] [Full Text] [Related]
5. Chemo-Photothermal Combination Therapy of HER-2 Overexpressing breast cancer Cells with Dual-Ordered Mesoporous Carbon@Silica Nanocomposite.
Tunçel A; Yurt F
Appl Biochem Biotechnol; 2023 Mar; 195(3):1904-1927. PubMed ID: 36401724
[TBL] [Abstract] [Full Text] [Related]
6. Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen.
Tabuchi Y; Tsujimoto M; Yamamoto K; Kosaka T; Sakaguchi K; Dobuchi N; Nishiguchi K; Shikata K
Cancer Chemother Pharmacol; 2023 Jan; 91(1):25-31. PubMed ID: 36401659
[TBL] [Abstract] [Full Text] [Related]
7. trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
[TBL] [Abstract] [Full Text] [Related]
8. Cost-effectiveness Analysis of trastuzumab Emtansine as Second-line Therapy for HER2-Positive breast cancer in China.
Zhang H; Zhang Y; Huang C; Wang J
Clin Drug Investig; 2021 Jun; 41(6):569-577. PubMed ID: 33876415
[TBL] [Abstract] [Full Text] [Related]
9. Impact of oncology pharmacist services on humanistic outcome in patients with breast cancer.
Khadela A; Bhikadiya V; Vyas B
J Oncol Pharm Pract; 2022 Mar; 28(2):302-309. PubMed ID: 33491576
[TBL] [Abstract] [Full Text] [Related]
10. De-escalated Therapy Omitting Anthracyclines for Stage I HER2-positive breast cancer: A Retrospective Observational Study.
Nakamoto S; Ikeda M; Kubo S; Yamamoto M; Yamashita T
In Vivo; 2020; 34(6):3713-3718. PubMed ID: 33144488
[TBL] [Abstract] [Full Text] [Related]
11. POU4F1 confers trastuzumab resistance in HER2-positive breast cancer through regulating ERK1/2 signaling pathway.
Wu D; Jia HY; Wei N; Li SJ
Biochem Biophys Res Commun; 2020 Dec; 533(3):533-539. PubMed ID: 32988584
[TBL] [Abstract] [Full Text] [Related]
12. Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft.
Pan A; Wang Z; Chen B; Dai W; Zhang H; He B; Wang X; Wang Y; Zhang Q
Drug Deliv; 2018 Nov; 25(1):1495-1503. PubMed ID: 29943651
[TBL] [Abstract] [Full Text] [Related]
13. Adjuvant Anti-HER2 Therapy, treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early breast cancer Patients.
Lambertini M; Campbell C; Bines J; Korde LA; Izquierdo M; Fumagalli D; Del Mastro L; Ignatiadis M; Pritchard K; Wolff AC; Jackisch C; Lang I; Untch M; Smith I; Boyle F; Xu B; Barrios CH; Baselga J; Moreno-Aspitia A; Piccart M; Gelber RD; de Azambuja E
J Natl Cancer Inst; 2019 Jan; 111(1):86-94. PubMed ID: 29878225
[TBL] [Abstract] [Full Text] [Related]
14. Calmodulin antagonist enhances DR5-mediated apoptotic signaling in tra-8 resistant triple negative breast cancer cells.
Fancy RM; Kim H; Napier T; Buchsbaum DJ; Zinn KR; Song Y
J Cell Biochem; 2018 Jul; 119(7):6216-6230. PubMed ID: 29663486
[TBL] [Abstract] [Full Text] [Related]
15. High-Sensitivity Troponin T and NT-proBNP Kinetics in breast cancer Chemotherapy.
Advani P; Hoyne J; Moreno-Aspita A; Dubin M; Brock S; Harlow C; Chumsri S; Suter T; Blackshear JL
Chemotherapy; 2017; 62(6):334-338. PubMed ID: 28704807
[TBL] [Abstract] [Full Text] [Related]
16. Cellular prion protein (PrP
Provenzano L; Ryan Y; Hilton DA; Lyons-Rimmer J; Dave F; Maze EA; Adams CL; Rigby-Jones R; Ammoun S; Hanemann CO
Oncogene; 2017 Nov; 36(44):6132-6142. PubMed ID: 28692055
[TBL] [Abstract] [Full Text] [Related]
17. Synergistic Combination of Multistage Magnetic Guidance and Optimized Ligand Density in Targeting a Nanoplatform for Enhanced cancer Therapy.
Chiang CS; Shen YS; Liu JJ; Shyu WC; Chen SY
Adv Healthc Mater; 2016 Aug; 5(16):2131-41. PubMed ID: 27337051
[TBL] [Abstract] [Full Text] [Related]
18. Hormone receptor status does not alter the effect of trastuzumab in breast cancer.
Ignatov T; Eggemann H; Burger E; Costa SD; Ignatov A
Endocr Relat Cancer; 2016 May; 23(5):349-55. PubMed ID: 27009140
[TBL] [Abstract] [Full Text] [Related]
19. A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of tra-8/DR5 Oligomers Predicts tra-8 Therapeutic Efficacy in breast and Pancreatic cancer Mouse Models.
Kim H; Buchsbaum DJ; Zinn KR
Mol Imaging Biol; 2016 Jun; 18(3):325-33. PubMed ID: 26552657
[TBL] [Abstract] [Full Text] [Related]
20. Caspase-8 activation by traIL monotherapy predicts responses to IAPi and traIL combination treatment in breast cancer cell lines.
Polanski R; Vincent J; Polanska UM; Petreus T; Tang EK
Cell Death Dis; 2015 Oct; 6(10):e1893. PubMed ID: 26426685
[TBL] [Abstract] [Full Text] [Related]
[Next]
